Chi‐Chih Cheng
Impact in
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
- Fungal Biology and Applications
- Clinical Biochemistry top 10%
- Paraoxonase enzyme and polymorphisms
Papers in
-
- Cell death mechanisms and regulation 4
- Ginseng Biological Effects and Applications 4
- Ubiquitin and proteasome pathways 1
- Oncology 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Shih-Lan Hsu (4 shared papers)Jung-Chou Chen (3 shared papers)Shih‐Lan Hsu (8 shared papers)Shu-Mei Yang (1 shared paper)Chi‐Ying F. Huang (2 shared papers)Chi-Wu Chiang (2 shared papers)Jung‐Chou Chen (2 shared papers)Chi‐Mei Hsueh (3 shared papers)
- Journals
- Cancer Letters (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)European Journal of Pharmacology (2 papers)Biochemical and Biophysical Research Communications (1 paper)The American Journal of Chinese Medicine (1 paper)
- Partner nations
- TaiwanUnited StatesIndia
In The Last Decade
Chi‐Chih Cheng
12 papers receiving 417 citations
Peers
Comparison fields: 5 of 68
- Pharmacology 73
- Clinical Biochemistry 34
- Cancer Research 66
- Complementary and alternative medicine 31
- Molecular Biology 262
Countries citing papers authored by Chi‐Chih Cheng
This map shows the geographic impact of Chi‐Chih Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Chih Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Chih Cheng more than expected).
Fields of papers citing papers by Chi‐Chih Cheng
This network shows the impact of papers produced by Chi‐Chih Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Chih Cheng. The network helps show where Chi‐Chih Cheng may publish in the future.
Co-authors
The 19 scholars most cited alongside Chi‐Chih Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 99 | |
| 2 | 2002 | 72 | |
| 3 | 2003 | 54 | |
| 4 | 2017 | 34 | |
| 5 | 2007 | 32 | |
| 6 | 2001 | 32 | |
| 7 | 2010 | 32 | |
| 8 | 2017 | 22 | |
| 9 | 2013 | 22 | |
| 10 | 2012 | 8 | |
| 11 | 2005 | 7 | |
| 12 | 2005 | 4 |
About Chi‐Chih Cheng
Chi‐Chih Cheng is a scholar working on Molecular Biology, Oncology, Clinical Biochemistry, Pharmacology and Pharmacology, having authored 12 papers that have together received 418 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (4 papers), Ginseng Biological Effects and Applications (4 papers), Paraoxonase enzyme and polymorphisms (3 papers), Hibiscus Plant Research Studies (2 papers), Cancer-related Molecular Pathways (2 papers), Cynara cardunculus studies (2 papers), Pharmacological Effects of Natural Compounds (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Pharmacology (73 citations), Clinical Biochemistry (34 citations), Cancer Research (66 citations), Complementary and alternative medicine (31 citations) and Molecular Biology (262 citations). Chi‐Chih Cheng has collaborated with scholars based in Taiwan, United States and India. Frequent co-authors include Shih-Lan Hsu, Jung-Chou Chen, Shih‐Lan Hsu, Shu-Mei Yang, Chi‐Ying F. Huang, Chi-Wu Chiang, Jung‐Chou Chen, Chi‐Mei Hsueh, Yew‐Min Tzeng and Guang‐Yuh Hwang. Their work appears in journals such as Cancer Letters, Cancer Chemotherapy and Pharmacology, European Journal of Pharmacology, Biochemical and Biophysical Research Communications and The American Journal of Chinese Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.